Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
Objectives: Multidrug-resistant (MDR) bacteria are a major public-health concern. Bacteriophage endolysins (lysins) can be used as novel antimicrobial agents against bacterial infections. In this study, a novel endolysin (LysSS) containing a lysozyme-like domain was evaluated for its antibacterial a...
Main Authors: | Shukho Kim, Da-Won Lee, Jong-Sook Jin, Jungmin Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716520300060 |
Similar Items
-
LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity
by: Shukho Kim, et al.
Published: (2020-11-01) -
LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms
by: He Liu, et al.
Published: (2024-03-01) -
Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study
by: Hayder Nsaif Jasim, et al.
Published: (2018-11-01) -
Novel phage lysin Abp013 against Acinetobacter baumannii
by: Chu, Joash Jun Keat, et al.
Published: (2022) -
A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
by: Minle Wu, et al.
Published: (2019-01-01)